Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Vancomycin in Revision Total Knee Replacement
NCT02020031Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2013
- Primary completion
- Jun 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vancomycin in surgical site infection (SSI) (2 arms), sponsored by Mayo Clinic. Primary endpoints: Mean Concentration of Vancomycin in Subcutaneous Fat at 24 hours and Mean Concentration of Vancomycin in Bone Samples at 24 hours. Started Dec 2013; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02020031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020031.